Tumor News and Research

RSS

Cancer cells' sticky fingers contribute to building a barrier surrounding breast tumors

Researchers at Turku University and Åbo Akademi University, Finland, have identified that finger-like cellular extensions called filopodia contribute to building a barrier surrounding breast tumors.

28 Oct 2022

Research reveals a differential clinical response to pembrolizumab in uterine cancer patients

New research from Yale Cancer Center reveals for the first time ever a differential clinical response to pembrolizumab in Lynch-like (mutated) vs methylated microsatellite instability-high (MSI-H) uterine cancer patients, increasing our understanding about the proportion of patients that derive benefit from immune checkpoint blockade.

28 Oct 2022

Commensal gut microbes from IBD patients produce genotoxic metabolites

Functional screening of human gut microbiota reveals a family of small molecule genotoxins called indolimines in patients with inflammatory bowel disease (IBD), according to a new study.

27 Oct 2022

RNA-sensing platform could help detect and selectively kill tumors, or edit the genome in specific cells

Researchers at the Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research at MIT have developed a system that can detect a particular RNA sequence in live cells and produce a protein of interest in response.

27 Oct 2022

Study sheds light on why some patients respond better than others to immunotherapy

Immunotherapy, a biotherapy that boosts the ability of the immune system to recognize and attack mutant tumor cells, has transformed the treatment landscape for patients battling cancer, which emerges from the progressive accumulation of DNA mutations.

27 Oct 2022

Study shows potential for eliminating surgery in a small subset of breast cancer patients

Researchers evaluate the efficacy of radiotherapy in patients with early-stage HER2-positive breast cancer or TNBC after neoadjuvant systemic therapy.

27 Oct 2022

AKT inhibitor shows promise in a trial matching new treatments to cancer patients based on genetic make-up of tumors

In a trial matching new treatments to cancer patients based on the genetic make-up of their tumors, 22% of the patients treated with the AKT inhibitor drug ipatasertib had their tumors shrink.

27 Oct 2022

Research opens up new avenues for overcoming treatment resistance in colorectal cancer

Colorectal cancer is one of the most common cancers. Its treatment is mainly based on chemotherapy. However, over time, chemotherapy induces resistance in the majority of patients, who end up being unresponsive to the drugs.

27 Oct 2022

Advanced type of nanoparticle could help fight hard-to-treat cancers

Nanoparticles, or tiny molecules that can deliver a payload of drug treatments and other agents, show great promise for treating cancers.

27 Oct 2022

Metabolite product from pomegranate improves the function of immune cells to fight against cancer

As part of an interdisciplinary project of the LOEWE Centre Frankfurt Cancer Institute (FCI), researchers from the Georg-Speyer-Haus in Frankfurt am Main, Germany, and Goethe University Frankfurt have succeeded in identifying a new approach for the therapy of colorectal cancer.

27 Oct 2022

Using magnetic bacteria to fight cancerous tumors

Researchers at ETH Zurich are planning to use magnetic bacteria to fight cancerous tumors. They have now found a way for these microorganisms to effectively cross blood vessel walls and subsequently colonize a tumor.

26 Oct 2022

COVID-19 and the gut

Researchers summarize current knowledge about underlying mechanisms and potential therapeutic approaches for the effects of COVID-19 on the gut.

26 Oct 2022

Discovery of small molecule enzyme inhibitor could be the key to treating cancers, autoimmune diseases

Researchers at the University of Illinois Chicago have found a small molecule capable of manipulating an immune process that plays an important role in cancers and autoimmune diseases.

25 Oct 2022

UArizona researchers working on a less toxic treatment for deadly breast cancer

After decades of research and two previous drug development attempts, things are looking promising for a team of University of Arizona researchers working on a less toxic treatment for a specific type of breast cancer.

25 Oct 2022

New approach to immunotherapy provokes a robust anti-tumor immune response in preclinical models

A new approach to cancer immunotherapy that uses one type of immune cell to kill another - rather than directly attacking the cancer - provokes a robust anti-tumor immune response that shrinks ovarian, lung, and pancreatic tumors in preclinical disease models, according to researchers at the Icahn School of Medicine at Mount Sinai in New York.

25 Oct 2022

Tumor News and Research

Cancer cells' sticky fingers contribute to building a barrier surrounding breast tumors

Research reveals a differential clinical response to pembrolizumab in uterine cancer patients

Commensal gut microbes from IBD patients produce genotoxic metabolites

RNA-sensing platform could help detect and selectively kill tumors, or edit the genome in specific cells

Study sheds light on why some patients respond better than others to immunotherapy

Study shows potential for eliminating surgery in a small subset of breast cancer patients

AKT inhibitor shows promise in a trial matching new treatments to cancer patients based on genetic make-up of tumors

Research opens up new avenues for overcoming treatment resistance in colorectal cancer

Advanced type of nanoparticle could help fight hard-to-treat cancers

Metabolite product from pomegranate improves the function of immune cells to fight against cancer

Using magnetic bacteria to fight cancerous tumors

COVID-19 and the gut

Discovery of small molecule enzyme inhibitor could be the key to treating cancers, autoimmune diseases

UArizona researchers working on a less toxic treatment for deadly breast cancer

New approach to immunotherapy provokes a robust anti-tumor immune response in preclinical models

Study offers a combination treatment option for patients with oligometastatic prostate cancer

Researchers focus on the identification of markers to improve head and neck cancer risk assessment

Scientists develop new method to study the proteins released by cells

Designing an Ultrasound Sticker that can Image your Internal Organs

Near-infrared spectroscopy can provide a cost-effective way to noninvasively monitor intracranial pressure

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News